Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (11)

« Back to Publications

Causes of excess non-lymphoma death in 58,000 patients with DLBCL diagnosed during 1997-2020 and followed for up to 25 years.

Challenger A. et al, (2026), Blood Adv

Histological types of invasive breast cancer in 830,000 women diagnosed in England during 1988-2016.

Probert J. et al, (2025), J Pathol Clin Res, 11

Histological types of invasive breast cancer in 830,000 women diagnosed in England during 1988–2016

Probert J. et al, (2025), Journal of Pathology Clinical Research, 11

Identification of recurrences in women diagnosed with early invasive breast cancer using routinely collected data in England.

Probert J. et al, (2025), BJC Rep, 3

Inequalities in geographic barriers and patient representation in lymphoma clinical trials across England.

Jones DA. et al, (2025), Br J Haematol, 206, 531 - 540

Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.

Holt F. et al, (2023), Int J Radiat Oncol Biol Phys, 117, 869 - 882

Ki67 and breast cancer mortality in women with invasive breast cancer.

Probert J. et al, (2023), JNCI Cancer Spectr, 7

Ki67 and breast cancer mortality in women with invasive breast cancer

PROBERT J., (2023), JNCI Cancer Spectrum

Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study.

Taylor C. et al, (2023), BMJ, 381

Proton beam therapy for early breast cancer: a systematic review and quantitative synthesis of adverse clinical outcomes

Holt F. et al, (2022), EUROPEAN JOURNAL OF CANCER, 175, S46 - S47

Methodology for tissue sample collection within a translational sub-study of the CHHiP trial (CRUK/06/016), a large randomised phase III trial in localised prostate cancer.

Wilkins A. et al, (2018), Clin Transl Radiat Oncol, 10, 1 - 6